In safe handling of antineoplastic drugs
Scholar“Research focused on Safe Handling of Antineoplastic Drugs and adjacent fields.”
16
H-index
685
Citations
Atalay has not officially claimed their profile. If you are Atalay, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
talay Mulu Fentie is a researcher working on Safe Handling of Antineoplastic Drugs. A fuller summary will appear once they update their profile.
Atalay's work has been cited 685 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Research themes (UN SDGs)
Research Square, Pharmaceutical Economics and Policy
PLoS ONE, Acute Lymphoblastic Leukemia research
BMC Cancer, Safe Handling of Antineoplastic Drugs
Cancer Management and Research, Palliative Care and End-of-Life Issues
PLOS Global Public Health, Palliative Care and End-of-Life Issues
Journal of Cancer Policy, Acute Lymphoblastic Leukemia research
JCO Global Oncology, Medication Adherence and Compliance
BMC Health Services Research, Pharmaceutical studies and practices
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you
